AR032479A1 - Nuevas composiciones farmaceuticas que contienen epinastina y pseudoefedrina - Google Patents

Nuevas composiciones farmaceuticas que contienen epinastina y pseudoefedrina

Info

Publication number
AR032479A1
AR032479A1 ARP010104692A ARP010104692A AR032479A1 AR 032479 A1 AR032479 A1 AR 032479A1 AR P010104692 A ARP010104692 A AR P010104692A AR P010104692 A ARP010104692 A AR P010104692A AR 032479 A1 AR032479 A1 AR 032479A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical compositions
pseudoefedrine
compositions containing
pharmaceutically acceptable
new pharmaceutical
Prior art date
Application number
ARP010104692A
Other languages
English (en)
Inventor
Victor Denker
Mabel Fernandez
Sara Abelaira
Daniel Bianchi
Francisco Gel
De Vidal Marta Cicconi
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8170029&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR032479(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of AR032479A1 publication Critical patent/AR032479A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Nuevas composiciones farmacéuticas orales que comprenden como compuestos farmacéuticamente activos una combinacion de una cantidad eficaz como antihistamínica de epinastina o una sal farmacéuticamente aceptable de la misma y de una cantidad eficaz como descongestionante de pseudoefedrina o una sal farmacéuticamente aceptable de la misma, y que comprenden además apropiados vehículos o excipientes farmacéuticamente aceptables. El invento se refiere además a métodos para la preparacion de estas composiciones y métodos de usarlos en el tratamiento de enfermedades y/ o trastornos alérgicos.
ARP010104692A 2000-10-06 2001-10-05 Nuevas composiciones farmaceuticas que contienen epinastina y pseudoefedrina AR032479A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00121828 2000-10-06

Publications (1)

Publication Number Publication Date
AR032479A1 true AR032479A1 (es) 2003-11-12

Family

ID=8170029

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP010104692A AR032479A1 (es) 2000-10-06 2001-10-05 Nuevas composiciones farmaceuticas que contienen epinastina y pseudoefedrina
ARP120102612A AR087240A2 (es) 2000-10-06 2012-07-19 Composiciones farmaceuticas que tienen epinastina y pseudoefedrina

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP120102612A AR087240A2 (es) 2000-10-06 2012-07-19 Composiciones farmaceuticas que tienen epinastina y pseudoefedrina

Country Status (32)

Country Link
EP (1) EP1326586B1 (es)
JP (1) JP2004521864A (es)
KR (1) KR20030036894A (es)
CN (1) CN1291715C (es)
AR (2) AR032479A1 (es)
AT (1) ATE424813T1 (es)
AU (2) AU2002212290B2 (es)
BG (1) BG107686A (es)
BR (1) BR0114339A (es)
CA (1) CA2423288C (es)
CZ (1) CZ2003945A3 (es)
DE (1) DE60137952D1 (es)
EA (1) EA007288B1 (es)
EC (1) ECSP034513A (es)
EE (1) EE200300138A (es)
ES (1) ES2323570T3 (es)
HK (1) HK1062196A1 (es)
HR (1) HRP20030259A2 (es)
HU (1) HUP0300970A3 (es)
IL (1) IL154884A0 (es)
ME (1) MEP39708A (es)
MX (1) MXPA03002900A (es)
MY (1) MY131159A (es)
NO (1) NO20031537L (es)
NZ (1) NZ525653A (es)
PE (1) PE20020324A1 (es)
PL (1) PL366123A1 (es)
SK (1) SK4052003A3 (es)
UA (1) UA75896C2 (es)
WO (1) WO2002028373A1 (es)
YU (1) YU24603A (es)
ZA (1) ZA200302079B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003000264A1 (en) * 2001-06-20 2003-01-03 Schering Corporation Antihistamines for the treatment of nasal congestion and nasal obstruction
JP4549618B2 (ja) * 2001-11-22 2010-09-22 第一三共ヘルスケア株式会社 鼻炎用組成物
BR0313175A (pt) * 2002-08-02 2005-06-14 Boehringer Ingelheim Int Formulações farmacêuticas compreendendo combinações de epinastina, pseudoefedrina e metilefedrina
JP5021155B2 (ja) * 2003-08-01 2012-09-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング エピナスチンと１種以上のさらなる抗−ｈ１−ヒスタミン類との組合せを含む皮膚疾患治療用製薬組成物
WO2005079752A2 (en) * 2004-02-11 2005-09-01 Rubicon Research Private Limited Controlled release pharmaceutical compositions with improved bioavailability

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0903151A1 (en) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
IL136461A0 (en) * 1997-12-23 2001-06-14 Schering Corp Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
WO2000021512A2 (en) * 1998-10-09 2000-04-20 Schering Corporation Composition and method for treating allergic diseases
US6613357B2 (en) * 2000-01-13 2003-09-02 Osmotica Corp. Osmotic device containing pseudoephedrine and an H1 antagonist

Also Published As

Publication number Publication date
JP2004521864A (ja) 2004-07-22
ES2323570T3 (es) 2009-07-21
PE20020324A1 (es) 2002-06-18
DE60137952D1 (de) 2009-04-23
AU1229002A (en) 2002-04-15
NZ525653A (en) 2006-07-28
HUP0300970A3 (en) 2005-03-29
EP1326586A1 (en) 2003-07-16
ECSP034513A (es) 2003-04-25
EE200300138A (et) 2003-08-15
EA007288B1 (ru) 2006-08-25
CA2423288A1 (en) 2002-04-11
NO20031537L (no) 2003-06-04
EA200300430A1 (ru) 2003-10-30
CN1468094A (zh) 2004-01-14
YU24603A (sh) 2006-05-25
KR20030036894A (ko) 2003-05-09
CZ2003945A3 (cs) 2003-08-13
ZA200302079B (en) 2004-05-05
PL366123A1 (en) 2005-01-24
ATE424813T1 (de) 2009-03-15
MEP39708A (en) 2011-02-10
UA75896C2 (en) 2006-06-15
NO20031537D0 (no) 2003-04-04
WO2002028373A1 (en) 2002-04-11
CN1291715C (zh) 2006-12-27
AR087240A2 (es) 2014-03-12
HRP20030259A2 (en) 2005-02-28
BG107686A (bg) 2003-11-28
BR0114339A (pt) 2003-12-09
MY131159A (en) 2007-07-31
EP1326586B1 (en) 2009-03-11
AU2002212290B2 (en) 2006-08-03
HUP0300970A2 (hu) 2003-11-28
HK1062196A1 (en) 2004-10-21
SK4052003A3 (en) 2003-09-11
MXPA03002900A (es) 2003-09-10
IL154884A0 (en) 2003-10-31
CA2423288C (en) 2007-11-13

Similar Documents

Publication Publication Date Title
ECSP045102A (es) Formulación farmacéutica que contiene 3-(3-dimetilamino-1-etil-2-metil-propil)fenol y proporciona una liberación retardada del ingrediente activo
AR037592A1 (es) Formulaciones farmaceuticas de 5,7,14-triazatetraciclo (10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaeno
ES2088312T3 (es) Formulacion de liberacion controlada que contiene tramadol.
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
UY28041A1 (es) Metodos de dosis bajas para el tratamiento de trastornos en los cuales la actividad del tnfa es perjudicial.
MX2007015480A (es) Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada.
CR8220A (es) Composicion de fexofenadina y proceso para su preparacion
AR039164A1 (es) Sales de venlafaxina de baja solubilidad en agua
UY29445A1 (es) Composiciones para la transmisión transmucosa oral de la metformina
ECSP024389A (es) Composiciones farmaceuticas solidas de valsartan
EA200401515A1 (ru) Новые фармацевтические композиции, содержащие флибансерин в полиморфной модификации а
CO5190674A1 (es) Tratamiento de desordenes neuroticos desordenes neuroticos
ECSP044986A (es) Composicion farmaceutica que comprende lumiracoxib
AR087240A2 (es) Composiciones farmaceuticas que tienen epinastina y pseudoefedrina
DE60102590T2 (de) Darreichungsformen zur behandlung von oralen mykosen
AR039221A1 (es) Combinaciones de epinastina, belladona y pseudoefedrina como formulaciones farmaceuticas
AR028448A1 (es) Formulaciones que contienen una droga glucocorticoide para el tratamiento de enfermedades broncopulmonares
WO2003092608A3 (en) Methionine aminopeptidase-2 inhibitors and methods of use thereof
AR033596A1 (es) Composicion farmaceutica para inyeccion intramuscular que contiene loxoprofeno
AR039162A1 (es) Formulaciones de venlafaxina de liberacion extendida
AR040764A1 (es) Formulaciones farmaceuticas de epinastina, pseudoefedrina y metilefedrina
UY26952A1 (es) Nuevas composiciones farmacéuticas que contienen epinastina y pseudoefedrina
SE0000303D0 (sv) Novel compounds
AR022348A1 (es) Una composicion farmaceutica para el tratamiento de los sintomas del tracto urinario inferior
AR030660A1 (es) Composicion farmaceutica para la prevencion o el tratamiento de una enfermedad asociada con un exceso de la produccion de il-12

Legal Events

Date Code Title Description
FC Refusal